×
Hero Background

Gastroparesis Treatment Companies

ID: MRFR/Pharma/2322-HCR
84 Pages
Rahul Gotadki
October 2025

Dedicated to digestive health, Gastroparesis Treatment companies focus on innovative therapies. Specializing in treatments for delayed gastric emptying, these organizations contribute to improved quality of life for individuals with gastroparesis. Their research and development efforts aim to address the unique challenges of this gastrointestinal condition.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Gastroparesis Treatment Market

Gastroparesis Treatment Key Companies

 

Latest Gastroparesis Treatment Companies Update


Evoke Pharma's Phase 3 Trial Success drug Ghrelin agonist, lonazepide, shows promise in a recent trial, potentially offering relief for Gastroparesis patients. This news sends Evoke's stock soaring and reignites hope for new treatment options.


Sumitomo Dainippon Pharma Partners with Medtronic collaboration combines Medtronic's expertise in gastric electrical stimulation (GES) with Sumitomo Dainippon's innovative drug pipeline, aiming to develop comprehensive treatment approaches for Gastroparesis.


GIThera and GastroIntestinal Health are developing AI algorithms to improve Gastroparesis diagnosis and personalize treatment plans based on individual patient data.


List of Gastroparesis Treatment Key Companies in the Market



  • Medtronic

  • Kimberly-Clark Corporation

  • Abbott Laboratories

  • Salix Pharmaceuticals, Inc

  • Boston Scientific Corporation

  • C. R. Bard, Inc

  • Janssen Global Services LLC

  • Cardinal Health, Inc.

  • Alfa Wassermann SPA

  • Evoke Pharma

  • Rhythm Pharmaceuticals, Inc